STOCK TITAN

SKYX Platforms (ticker: SKYX) director receives new equity awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SKYX Platforms Corp. director Efrat L. Greenstein Brayer received equity awards consisting of stock and options. On March 31, 2026, she was granted 16,000 shares of restricted common stock that vested immediately and 16,000 stock options with a $1.12 exercise price, expiring on March 31, 2031, under the non-employee director compensation program.

Following the grant, she directly holds 73,000 shares of common stock. She also holds previously granted stock options covering 9,000 shares at an exercise price of $12.34 expiring on March 11, 2027, 16,000 shares at $3.28 expiring on April 5, 2028, 16,000 shares at $1.09 expiring on April 4, 2029, and 16,000 shares at $1.26 expiring on March 27, 2030. The newly granted options vest in twelve equal monthly installments beginning on April 30, 2026.

Positive

  • None.

Negative

  • None.

Insights

Routine director equity grant adds modest exposure with staggered option strikes.

Director Efrat L. Greenstein Brayer received 16,000 restricted shares that vested immediately and 16,000 stock options at an exercise price of $1.12, vesting monthly over a year starting April 30, 2026. These awards come from the non-employee director compensation program, indicating standard board compensation rather than a discretionary market trade.

After the grant, she holds 73,000 common shares plus several option packages with exercise prices from $1.09 to $12.34 and expirations between 2027 and 2031. The filing shows no open-market buying or selling, so the informational signal is limited to a modest increase in long-term equity-based incentives.

Insider Greenstein Brayer Efrat L
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 16,000 $0.00 --
Grant/Award Common Stock, no par value 16,000 $0.00 --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
Holdings After Transaction: Stock Option (right to buy) — 16,000 shares (Direct); Common Stock, no par value — 73,000 shares (Direct)
Footnotes (1)
  1. Represents shares of restricted stock, which vested immediately upon grant and were granted pursuant to the non-employee director compensation program. Options vest in twelve equal monthly installments, on the last day of each month, beginning on April 30, 2026. These options were granted pursuant to the non-employee director compensation program.
Restricted stock grant 16,000 shares Restricted common stock vested immediately on March 31, 2026
New option grant 16,000 options at $1.12 Exercise price with expiration on March 31, 2031
Common shares held 73,000 shares Total direct SKYX common stock after reported grant
Legacy option position 1 9,000 shares at $12.34 Stock options expiring March 11, 2027
Legacy option position 2 16,000 shares at $3.28 Stock options expiring April 5, 2028
Legacy option position 3 16,000 shares at $1.09 Stock options expiring April 4, 2029
Legacy option position 4 16,000 shares at $1.26 Stock options expiring March 27, 2030
restricted stock financial
"Represents shares of restricted stock, which vested immediately upon grant"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
non-employee director compensation program financial
"were granted pursuant to the non-employee director compensation program"
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vest in twelve equal monthly installments financial
"Options vest in twelve equal monthly installments, on the last day of each month"
exercise price financial
"conversion_or_exercise_price": "1.1200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greenstein Brayer Efrat L

(Last)(First)(Middle)
C/O SKYX PLATFORMS CORP.
2855 W. MCNAB ROAD

(Street)
POMPANO BEACH FLORIDA 33069

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SKYX Platforms Corp. [ SKYX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, no par value03/31/2026A16,000(1)A$073,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$1.1203/31/2026A16,00004/30/2026(2)03/31/2031Common Stock, no par value16,000$016,000D
Stock Option (right to buy)$12.3403/31/202203/11/2027Common Stock, no par value9,0009,000D
Stock Option (right to buy)$3.2804/30/202304/05/2028Common Stock, no par value16,00016,000D
Stock Option (right to buy)$1.0904/30/202404/04/2029Common Stock, no par value16,00016,000D
Stock Option (right to buy)$1.2603/31/202503/27/2030Common Stock, no par value16,00016,000D
Explanation of Responses:
1. Represents shares of restricted stock, which vested immediately upon grant and were granted pursuant to the non-employee director compensation program.
2. Options vest in twelve equal monthly installments, on the last day of each month, beginning on April 30, 2026. These options were granted pursuant to the non-employee director compensation program.
/s/ Efrat L. Greenstein Brayer04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)